Discover how PSMC6, a proteasome subunit, plays a critical role in cisplatin-resistant ovarian cancer and opens new therapeutic possibilities.
Discover how targeting neddylation with MLN4924 could overcome cisplatin resistance in ovarian cancer, offering new hope for patients with recurrent disease.